Contract HHSF222200660249P
Asuragen Incorporated · Department Of Health And Human Services · September 15, 2006
Asuragen Incorporated was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 15, 2006 for $8,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Jefferson, AR. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on February 22, 2011.
Contract details
- PIID
- HHSF222200660249P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Other Professional Services
- Place of performance
- Jefferson, AR
- First action
- September 15, 2006
- Latest action
- February 22, 2011
Description
ASURAGEN QC TEST (POGRIBNY E7181)
Modification timeline
-
February 22, 2011Mod 2$-1.1K
-
February 8, 2007Mod 1$0
-
September 15, 2006Base award$8.9K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSF222200660249P?
Contract HHSF222200660249P is a federal contract awarded to Asuragen Incorporated by Department Of Health And Human Services on September 15, 2006 for $8,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.
Who won contract HHSF222200660249P?
Asuragen Incorporated won contract HHSF222200660249P from Department Of Health And Human Services.
How much is contract HHSF222200660249P worth?
Contract HHSF222200660249P has obligated $8,000 to date.